NLM Digital Collections

Search

Start Over Subjects Economics, Pharmaceutical ✖Remove constraint Subjects: Economics, Pharmaceutical

3. Congreso Internacional de Derecho y Economia Farmaceutica

Author(s):
Congreso Internacional de Derecho y Economia Farmaceutica (1990 : Granada, Spain)
Publication:
[Grenada, Spain : Cátedra de Historia de la Farmacia y Legislación Farmacéutica, Facultad de Farmacia, Campus Universitario de la Cartuja, 1990]
Subject(s):
Legislation, Pharmacy
Economics, Pharmaceutical
Drug Industry -- legislation & jurisprudence
Drug Industry -- economics

5. Cost savings

Author(s):
Steiner, David J., author
Publication:
[Toronto, Ontario] : Thomson Reuters, 23-December-2019
Subject(s):
Cost Control -- legislation & jurisprudence
Cost Savings
Drug Costs -- legislation & jurisprudence
Economics, Pharmaceutical
Legislation, Drug
Access to Information
Biosimilar Pharmaceuticals
Commerce
Conflict of Interest
Drug Industry
Insurance, Pharmaceutical Services
Managed Care Programs
Medicaid -- economics
Medicare Part D -- economics
Patents as Topic
State Government
Humans
United States

7. Drug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, DC : United States Government Accountability Office, July 11, 2018
Subject(s):
Drug Costs
Economics, Pharmaceutical
Pharmacies -- economics
Contract Services
Government Regulation
United States
United States. Health Resources and Services Administration.

8. Drug discount program: status of agency efforts to improve 340B program oversight : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate

Publication:
Washington, DC : United States Government Accountability Office, May 15, 2018
Subject(s):
Drug Costs
Economics, Pharmaceutical
Government Regulation
Medicaid -- economics
United States
United States. Health Resources and Services Administration.

9. Drug discount program: update on agency efforts to improve 340B program oversight : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives

Publication:
Washington, D.C. : U.S. Government Accountability Office, July 18, 2017
Subject(s):
Government Regulation
Insurance, Pharmaceutical Services -- economics
Medicaid -- economics
Contract Services
Economics, Pharmaceutical
Forecasting
Government Programs -- statistics & numerical data
Insurance, Health, Reimbursement
Pharmacies -- statistics & numerical data
Pharmacies -- trends
Humans
United States
United States. Health Resources and Services Administration.